Severe pneumonia in mycophenolate mofetil combined with low-dose corticosteroids-treated patients with immunoglobulin A nephropathy
The tolerance of mycophenolate mofetil (MMF; Shanghai Roche, China) in Lee Classes III, IV, and V immunoglobulin A nephropathy (IgAN) remains unclear. This article reports nine cases of severe pneumonia (SP), including pneumocystis pneumonia (PCP) and cytomegalovirus (CMV) pneumonia, and its risk fa...
Main Authors: | Qi-Jun Wan, Hao-Fei Hu, Yong-Cheng He, Shao-Dong Luan, Hong-Tao Chen, Hong-Ping Liu, Tong Li, Yi Xu, Hui-Li Xu, Ying Liao |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | Kaohsiung Journal of Medical Sciences |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1607551X14002034 |
Similar Items
-
Mycophenolate mofetil may protect against Pneumocystis carinii pneumonia in renal transplanted patients Micofenolato mofetil pode proteger contra a pneumonia por Pneumocystis carinii em transplantados renais
by: Luiz Sergio Azevedo, et al.
Published: (2005-06-01) -
Does mycophenolate mofetil increase the risk of cytomegalovirus infection in solid organ transplant recipients?: A mini-review
by: Alice Tung Wan Song, et al. -
Efficacy and safety of mycophenolate mofetil in patients with IgA nephropathy: an update meta-analysis
by: Bing Du, et al.
Published: (2017-07-01) -
Hydroxychloroquine may reduce risk of Pneumocystis pneumonia in lupus patients: a Nationwide, population-based case-control study
by: Kai-Jieh Yeo, et al.
Published: (2020-02-01) -
Mycophenolate mofetil as an alternative treatment for autoimmune hepatitis
by: Seung Woon Park, et al.
Published: (2016-06-01)